KK2845

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KK2845, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]